As A GUIDE to the proliferative activity of cell populations the labelling index, 1s (i.e. the proportion of cells which are in the phase of DNA synthesis) is generally preferred to the mitotic index for several reasons: the labelling index is a larger fraction than the mitotic index and is therefore easier to estimate accurately; labelled cells are more easily recognized and counted than mitoses; and, in the case of human tumour tissue, labelling is less likely to be affected by the trauma of surgery (Steel and Bensted, 1965) . A large number of tn vitro labelling studies have beeni carried out on human tumour tissue but little information is available on the labelling properties of children's tumours (Malaise, Chavaudra and Tubiana, 1973 and a mean in vitro labelling index of 11 8%, which agrees well with the in vivo labelling index of 11.0% reported by Wagner and Kaser (1970) .
One of the 3 retinoblastomata had much higher proliferative indices than the other 2. Similarly, there was a marked difference between the results for the 2 medulloblastomata. We found no clinical explanation for these differences. It is interesting, but possibly coincidental, that patient S.D., whose tumour gave high proliferative indices, had a more rapid decline than the other 2 patients with brain tumours, who are alive and well 1 and 2 years respectively after operation. In contrast, patient J.Wi., whose tumour has extremely low indices, had a long history and despite being given a poor prognosis is still alive and well 2 years later.
All studies using in vitro labelling techniques are based on the assumption that the in vitro labelling index represents the value that would have been obtained in vivo. A number of studies (Fabrikant, Wisseman and Vitak, 1969; Denekamp and Kallman, 1973; Malaise et al., 1973) support the view that if groups of similar tumours are considered, then the patterns of in vitro and in vivo labelling are similar. One aim of carrying out labelling studies on human tumour tissue has been to assess the usefulness of the labelling index in predicting the response of tumours to chemotherapy and radio- therapy. As far as we are aware, no examples have been reported in which a knowledge of the labelling index has been shown to be useful in an individual case. There is, however, evidence to suggest a correlation between the mean labelling index of a group of similar tumours and their general response to therapy. Malaise et al. (1973) divided 242 tumours into 5 histological groups which were in order of descending labelling index: embryonal tumours, " haematosarcomata" (i.e. Burkitt's lymphoma, Hodgkin's disease, lymphosarcoma), mesenchymal sarcomata, squamous cell carcinomata and adenocarcinomata. The 2 classes of tumours with the highest indices (embryonal tumours and ' haematosarcomata ") also tend to have the best response to chemotherapy.
